glyphosate
Commercial- Indications
- Herbicide
Company intelligence / Profile preview
Monsanto was a global leader in genetically engineered seeds and glyphosate-based herbicides. It pioneered commercial GMOs such as Roundup Ready soybeans and corn. The company’s products were widely adopted but also controversial due to environmental and health concerns. At the time of its acquisition by Bayer in June 2018 for $63 billion, Monsanto had a broad commercial portfolio but faced significant litigation over alleged health effects of its products like Roundup.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monsanto.